myeloma Archive

Latest Posts

Dana-Farber to present research on myeloma progression from precursor conditions

Dana-Farber Cancer Institute scientists will present research marking significant advances against the hematologic cancer multiple myeloma at the American Society of Hematology (ASH) Annual Meeting Dec. 1-4. Their findings provide new insights into the progression of the disease from precursor conditions

TJP1 protein can also pick out more than one myeloma patients maximum likely to gain from proteasome inhibitors

nice advantage from proteasome inhibitors such as bortezomib, as well as aggregate procedures toenhance proteasome inhibitor sensitivity, consistent with a take a look at led with the aid of The College of Texas MD Anderson Cancer Center. a couple of myeloma

Researchers broaden novel ailment version to examine a couple of myeloma

Researchers at Sylvester Comprehensive Most cancers Center on the College of Miami Miller College of medication have developed an animal version that permits them to better recognize the mechanisms thatresult in the development of multiple myeloma, a hematologic Most cancers of